Clinical

Dataset Information

0

An Open-Label Study to Evaluate the Long-term Safety of Subcutaneous MOA-728 forTreatment of Opioid-Induced Constipation in Subjects With Nonmalignant PainEstudio abierto para evaluar la seguridad a largo plazo de MOA-728 subcutánea para el tratamiento del estreñimiento inducido por opiáceos en sujetos con dolor de origen no maligno


ABSTRACT: Primary: The primary objective of the study is to evaluate the long-term safety and tolerability of the subcutaneous formulation of MOA-728 in subjects with opioid-induced constipation who have nonmalignant pain. Primary endpoints: Safety and tolerability will be evaluated by collection of adverse events, laboratory assessments, physical examinations, vital signs measurements, electrocardiograms, Pain Intensity Scale, and the opioid withdrawal scales.

DISEASE(S): Opioid-induced Constipation In Subjects With Non-malignant Paintratamiento Del Estreñimiento Inducido Por Opiáceos En Sujetos Con Dolor De Origen No Maligno,Constipation

PROVIDER: 2525282 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2525287 | ecrin-mdr-crc
| S-EPMC7147674 | biostudies-literature
| S-EPMC10197789 | biostudies-literature
| 2525209 | ecrin-mdr-crc
| S-EPMC9578731 | biostudies-literature
| 2530510 | ecrin-mdr-crc
| 2045578 | ecrin-mdr-crc
| 2049918 | ecrin-mdr-crc
| S-EPMC7442931 | biostudies-literature
| 2031936 | ecrin-mdr-crc